Basics Akero Therapeutics, Inc. IPO Date: July 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $3.58B Activated in VL: True Average Daily Range Avg Daily Range: $0.78 | 2.84% Avg Daily Range (30 D): $1.01 | 2.06% Avg Daily Range (90 D): $1.08 | 2.28% Institutional Daily Volume Avg Daily Volume: .53M Avg Daily Volume (30 D): .75M Avg Daily Volume (90 D): 1.09M Trade Size Avg Trade Size (Sh.): 64 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 2,537 Avg Inst. Trade: $2.76M Avg Inst. Trade (30 D): $4.23M Avg Inst. Trade (90 D): $4.65M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.11M Avg Closing Trade (30 D): $7.26M Avg Closing Trade (90 D): $8.78M Avg Closing Volume: 122.34K     News Aug 28, 2025 @ 11:00 AM Akero Therapeutics to Present at the Morgan Stanle... Source: Akero Therapeutics Aug 14, 2025 @ 10:30 PM Akero Therapeutics Announces Lancet Publication of... Source: Akero Therapeutics May 11, 2025 @ 7:21 AM Akero Therapeutics und HistoIndex präsentieren ... Source: N/A May 11, 2025 @ 7:21 AM Akero Therapeutics et HistoIndex présentent de ... Source: N/A May 10, 2025 @ 4:28 PM Akero Therapeutics présente les résultats de... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-3.8 $-.86 $-.9 Diluted EPS $-3.8 $-.86 $-.9 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -283.96M $ -70.51M $ -70.73M Operating Income / Loss $ -321.48M $ -80.87M $ -80.88M Cost of Revenue $ $ $ Net Cash Flow $ -89.91M $ 34.53M $ -154.32M PE Ratio